Ann: Incannex to Acquire APIRx Pharmaceuticals, page-62

This is a great annoucement - but it all in terms of LT potential. The highlights include IP and pre-clinical and clinical trials- this is all good stuff for many here who may want to hold for years. But maybe it will convince more to stay - who knows.
I bought in only about a few months at 50c (intending for a short term trade and to sell before nasdaq listing) but after the events of the past few months and looking further and further into IHL, I can't sell, the LT potential is too good. This is a multi year hold.